Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease

Jessie Theuns, Aline Verstraeten, Kristel Sleegers, Eline Wauters, Ilse Gijselinck, Stefanie Smolders, David Crosiers, Ellen Corsmit, Ellen Elinck, Manu Sharma, Rejko Krüger, Suzanne Lesage, Alexis Brice, Sun Ju Chung, Mi Jung Kim, Young Jin Kim, Owen A. Ross, Zbigniew K. Wszolek, Ekaterina Rogaeva, Zhengrui XiAnthony E. Lang, Christine Klein, Anne Weissbach, George D. Mellick, Peter A. Silburn, Georgios M. Hadjigeorgiou, Efthimios Dardiotis, Nobutaka Hattori, Kotaro Ogaki, Eng King Tan, Yi Zhao, Jan Aasly, Enza Maria Valente, Simona Petrucci, Grazia Annesi, Aldo Quattrone, Carlo Ferrarese, Laura Brighina, Angela Deutschländer, Andreas Puschmann, Christer Nilsson, Gaëtan Garraux, Mark S. LeDoux, Ronald F. Pfeiffer, Magdalena Boczarska-Jedynak, Grzegorz Opala, Demetrius M. Maraganore, Sebastiaan Engelborghs, Peter Paul De Deyn, Patrick Cras, Marc Cruts, Christine Van Broeckhoven

Research output: Contribution to journalArticle

38 Scopus citations

Abstract

Objectives: The objective of this study is to clarify the role of (G4C2)n expansions in the etiology of Parkinson disease (PD) in the worldwide multicenter Genetic Epidemiology of Parkinson's Disease (GEO-PD) cohort. Methods: C9orf72 (G4C2)n repeats were assessed in a GEO-PD cohort of 7,494 patients diagnosed with PD and 5,886 neurologically healthy control individuals ascertained in Europe, Asia, North America, and Australia. Results: A pathogenic (G4C2)n.60 expansion was detected in only 4 patients with PD (4/7,232; 0.055%), all with a positive family history of neurodegenerative dementia, amyotrophic lateral sclerosis, or atypical parkinsonism, while no carriers were detected with typical sporadic or familial PD. Meta-analysis revealed a small increase in risk of PD with an increasing number of (G4C2)n repeats; however, we could not detect a robust association between the C9orf72 (G4C2)n repeat and PD, and the population attributable risk was low. Conclusions: Together, these findings indicate that expansions in C9orf72 do not have a major role in the pathogenesis of PD. Testing for C9orf72 repeat expansions should only be considered in patients with PD who have overt symptoms of frontotemporal lobar degeneration/amyotrophic lateral sclerosis or apparent family history of neurodegenerative dementia or motor neuron disease.

Original languageEnglish (US)
Pages (from-to)1906-1913
Number of pages8
JournalNeurology
Volume83
Issue number21
DOIs
StatePublished - Nov 1 2014

    Fingerprint

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Theuns, J., Verstraeten, A., Sleegers, K., Wauters, E., Gijselinck, I., Smolders, S., Crosiers, D., Corsmit, E., Elinck, E., Sharma, M., Krüger, R., Lesage, S., Brice, A., Chung, S. J., Kim, M. J., Kim, Y. J., Ross, O. A., Wszolek, Z. K., Rogaeva, E., ... Van Broeckhoven, C. (2014). Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease. Neurology, 83(21), 1906-1913. https://doi.org/10.1212/WNL.0000000000001012